This receptor is overexpressed in many primary cancers (i.e., brain, breast, colon, melanoma, prostate and ovary) (see [14] for a review), and some studies proposed Ptch1 as an early marker of thyroid and gastric cancers [15,16]. Here, PTCH1 is linked to melanoma.